Search

Search Constraints

You searched for: Author/Creator Beauchesne, Patrick

Search Results

1. A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma. (28th September 2018)

3. Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas. (13th October 2015)

4. Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Issue 5 (18th December 2013)

6. Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG). (22nd February 2018)